Oramed Pharmaceuticals Inc.
[WKN: A1CTNU | ISIN: US68403P2039]
2,364€ -0,55%
Echtzeit-Aktienkurs Oramed Pharmaceuticals Inc.
Bid: Ask:
Reuters Kategorien
dpa-AFX Compact / dpa-AFX PRO Kategorien
Traderfox: dpa-AFX ProFeed Kategorien
dpa-AFX ProFeed Kategorien

Oramed Letter to Shareholders

Topline Pivotal Phase 3 Oral Insulin Data Expected Mid-January 2023 Phase 2 NASH Trial Achieved Primary and Secondary Endpoints Definitive…